Seer (SEER) Gains from Investment Securities (2020 - 2026)
Seer (SEER) recorded quarterly Gains from Investment Securities of -$21000.0 in Q1 2026, down 170.0% quarter-over-quarter from $30000.0 in Q4 2025, and down 110.51% on a YoY basis from $199862.0 in Q1 2025.
Seer (SEER) Gains from Investment Securities (2020 - 2026) Analysis & Trends
Seer's Gains from Investment Securities history runs 7 years deep, the most recent figure standing at -$21000.0 for Q1 2026.
- In Q1 2026, Gains from Investment Securities fell 110.51% year-over-year to -$21000.0; the TTM figure through Mar 2026 stood at -$479000.0 (down 339.67% YoY), while the FY2025 annual figure was $13.2 million, changed 0.19% from the prior year.
- Gains from Investment Securities was -$21000.0 for Q1 2026 at Seer, down from $30000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $14.2 million in Q2 2024 to a low of -$443000.0 in Q4 2024.
- Historically, Gains from Investment Securities has averaged $3.7 million across 5 years, with a median of $199862.0 in 2025.
- Biggest YoY gain for Gains from Investment Securities was 48946.39% in 2024; the steepest drop was 188.6% in 2024.
- A 5-year view of Gains from Investment Securities shows it stood at $13.0 million in 2022, then slumped by 96.14% to $500000.0 in 2023, then plunged by 188.6% to -$443000.0 in 2024, then jumped by 106.77% to $30000.0 in 2025, then tumbled by 170.0% to -$21000.0 in 2026.
- The last three Gains from Investment Securities figures came in at -$21000.0 (Q1 2026), $30000.0 (Q4 2025), and $13.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Seer | 96.59 Mn | 96.59 Mn | 982,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21,000.00 |
| Mar 31, 2026 | -21,000.00 |
| Dec 31, 2025 | 30,000.00 |
| Dec 31, 2025 | 30,000.00 |
| Sep 30, 2025 | 13.53 Mn |
| Sep 30, 2025 | 13.53 Mn |
| Jun 30, 2025 | 398,800.00 |
| Jun 30, 2025 | 398,800.00 |
| Mar 31, 2025 | 199,862.00 |
| Mar 31, 2025 | 199,862.00 |
| Dec 31, 2024 | -443,000.00 |
| Dec 31, 2024 | -443,000.00 |
| Sep 30, 2024 | 13.81 Mn |
| Sep 30, 2024 | 13.81 Mn |
| Jun 30, 2024 | 14.17 Mn |
| Jun 30, 2024 | 14.17 Mn |
| Mar 31, 2024 | -45,000.00 |
| Mar 31, 2024 | -45,000.00 |
| Dec 31, 2023 | 500,000.00 |
| Dec 31, 2023 | 500,000.00 |